Prevalence of HPV and variation of HPV 16/HPV 18 E6/E7 genes in cervical cancer in women in South West China

Journal of Medical Virology

Volumn 86, Issue 11, 2014, Pages 1926-1936

  Yang, Lijuan ^a   Yang, Hongying ^b   Wu, Kun ^b   Shi, Xinan ^c   Ma, Shaohui ^a   Sun, Qiangming ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c Southwest Guizhou Vocational and Technical College   (China)

Author keywords

Gene polymorphism; High risk HPV; Phylogenetic trees; Selection pressures; Single nucleotide change

Indexed keywords

NUCLEOTIDE; ONCOPROTEIN;

ADULT; AGED; ALPHA HELIX; ARTICLE; BETA SHEET; CANCER PATIENT; CHINA; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS E6/E7; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; INFECTION RATE; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MUTATION; NON SYNONYMOUS MUTATION; OUTPATIENT; PAPILLOMAVIRUS INFECTION; PHYLOGENETIC TREE; PROTEIN SECONDARY STRUCTURE; UTERINE CERVIX CANCER; VIRUS GENE; CLUSTER ANALYSIS; COMPLICATION; DNA SEQUENCE; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR GENETICS; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; PREVALENCE; SEQUENCE HOMOLOGY; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ADULT; AGED; CHINA; CLUSTER ANALYSIS; FEMALE; GENETIC VARIATION; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; PREVALENCE; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; UTERINE CERVICAL NEOPLASMS;

EID: 84908209403     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24043     Document Type: Article

References (51)

1. Bae JH, Lee SJ, Kim CJ, Hur SY, Park YG, Lee WC, Kim YT, Ng TL, Bock HL, Park JS. 2008. Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol 18:788-794.
2. Balz V, Scheckenbach K, Götte K. 2003. Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated analysis of p53 exons 2-11 and human papillomavirus 1618 E6 transcripts in 123 unselected tumor specimens. Cancer Res 63:1188-1191.
3. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 87:796-802.
4. Burchell AN, Winer RL, de Sanjosé S, Franco EL. 2006. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 24:S52-S61.
5. Cai HB, Chen CC, Ding XH. 2010. Human papillomavirus type 16 E6 gene variations in Chinese population. Eur J Surg Oncol (EJSO) 36:160-163.
6. Cerqueira DM, Moraes DdS, Camara GNL, Amaral FA, Oyama CNR, dos Santos MQC, Martins CRF. 2006. High HPV genetic diversity in women infected with HIV-1 in Brazil. Arch Virol 152:75-83.
7. Chan PK, Lam CW, Cheung TH, Li WW, Lo KW, Chan MY, Cheung JL, Cheng AF. 2002. Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst 94:1249-1253.
8. Chang CH, Chen TH, Hsu RC, Chou PH, Yang JJ, Hwang GY. 2005. The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan. J Clin Virol 32:33-37.
9. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, Ghissassi F. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol 6:204-204.
10. DiMaio D, Liao JB. 2006. Human Papillomaviruses and Cervical Cancer. Adv Virus Res 66:125-159.
11. Ding XH, Zhang F, Cai HB, Yang ZQ. 2010. The study of gene variation and phylogenetic analysis of HPV16 E6 and E7 gene in Hubei, China. Bing Du Xue Bao 26:368-372.
12. Doorbar J. 2006. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110:525-541.
13. Felsenstein J. 1982. Numerical methods for inferring evolutionary trees. Q Rev Biol 57:379-404.
14. Felsenstein J. 1985. Confidence Limits on Phylogenies: An Approach Using the Bootstrap. Evolution 39:783-791.
15. Felsenstein J. 1989. PHYLIP-phylogeny inference package (version 3.2). Cladistics 5:163-166.
16. Hamza AA, Robene-Soustrade I, Jouen E, Lefeuvre P, Chiroleu F, Fisher-Le Saux M, Gagnevin L, Pruvost O. 2012. MultiLocus sequence analysis-and amplified fragment length polymorphism-based characterization of xanthomonads associated with bacterial spot of tomato and pepper and their relatedness to xanthomonas species. Syst Appl Microbiol 35:183-190.
17. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, Bratti MC, Sherman ME, Scarpidis U, Lin QQ, Terai M, Bromley RL, Buetow K, Apple RJ, Burk RD. 2001. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93:315-318.
18. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, IceKahn JP, Kiviat N, Lancaster W, Mavromara-Nazos P. 1993. The genetic drift of human papillomavirus type16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 67:6413-6423.
19. Ho L, Chan SY, Chow V, Chong T, Tay SK, Villa LL, Bernard HU. 1991. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol 29:1765-1772.
20. Husman A-MdR, Walboomers JMM, Brule AJCvD, Meijer CJLM, Snijders PJF. 1995. The use of general primers GP5 and GP6 elongated at their 3' ends with. J Gen Virol 76:1057-1062. Kenter GG, Welters MJP, Valentijn ARPM, Lowik MJG. 2009. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med 361:1838-1847.
21. Kenter GG, Welters MJP, Valentijn ARPM, Lowik MJG. 2009. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med 361:1838-1847.
22. Koji Matsumoto HY, Shunsuke Nakagawa. 2000. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 156:159-165.
23. Lai CH, Chao A, Chang CJ, Chao FY, Huang HJ, Hsueh S, Lin CT, Cheng HH, Huang CC, Yang JE, Wu TI, Chou HH, Chang TC. 2008. Host and viral factors in relation to clearance of human papillomavirus infection: a cohort study in Taiwan. Int J Cancer 123:1685-1692.
24. Lai HC, Sun CA, Yu MH, Chen HJ, Liu HS, Chu TY. 1999. Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types. Int J Cancer 84:553-557.
25. Li-na P, Yan-kui W, Bing L, Yuan-fang L, Xue-zhen Z. 2010. Mutations of E6 and E2 oncogenes of human papillomavirus 16 in women with cervical carcinoma in Qingdao. Chin Clin Oncol 15:608-612.
26. Lin QQ, Yu SZ, Qu W, Cruz Y, Burk RD. 1998. Human papillomavirus types 52 and 58. Int J Cancer 75:484-485.
27. Muñoz N, Bosch FX, Sanjosé Sd, Herrero R, Xavier Castellsagué. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
28. Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, Grace M, Huh K. 2004. Mechanisms of Human Papillomavirus-Induced Oncogenesis. J Virol 78:11451-11460.
29. Narisawa-Saito M, Kiyono T. 2007. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Sci 98:1505-1511.
30. Nei M, Gojobori T. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3:418-426.
31. Pista A, Oliveira A, Barateiro A, Costa H, Verdasca N, Paixao MT. 2007. Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal. J Med Virol 79:1889-1897.
32. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD. 1997. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35:1304-1310.
33. Riemer AB, Keskin DB, Zhang G, Handley M, Anderson KS, Brusic V, Reinhold B, Reinherz EL. 2010. A Conserved E7-derived cytotoxic T lymphocyte epitope expressed on human papillomavirus 16-transformed HLA-A2+ Epithelial Cancers. J Biol Chem 285:29608-29622.
34. S Andersson MA, Rylander E, Strand A, Larsson B, Sällström J, Wilander E. 2000. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer 83:307-310.
35. Sasagawa T, Basha W, Yamazaki H, Inoue M. 2001. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 10:45-52.
36. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet 370:890-907.
37. Strati K, Lambert PF. 2007. Role of Rb-dependent and Rb-independent functions of papillomavirus E7 oncogene in head and neck cancer. Cancer Res 67:11585-11593.
38. Sun Z, Ren G, Cui X, Zhou W, Liu C, Ruan Q. 2011. Genetic diversity of HPV-16 E6, E7, and L1 genes in women with cervical lesions in Liaoning Province, China. Int J Gynecol Cancer 21:551-558.
39. Sun ZR, Ji YH, Zhou WQ, Zhang SL, Jiang WG, Ruan Q. 2010. Characteristics of HPV prevalence among women in Liaoning province, China. Int J Gynaecol Obstet 109:105-109.
40. Vaeteewoottacharn K, Jearanaikoon P, Ponglikitmongkol M. 2003. Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas. Anticancer Res 23:1927-1931.
41. Wheeler CM, Yamada T, Hildesheim A, Jenison SA. 1997. Human papillomavirus type 16 sequence variants identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 35:11-19.
42. Wu EQ, Ren Y, Qiu AD, Zhang GN, Jiang CL, Fan Y, Yu XH, Wu YG, Zha X, Kong W. 2006. Analysis of E6 variants of human papillomavirus Type 18, 45 isolated. Chem J Chinese U 27:263-267.
43. Xi LF, Koutsky LA, Galloway DA, Kuypers J, Hughes JP, Wheeler CM, Holmes KK, Kiviat NB. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89:796-802.
44. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, Wheeler CM. 1997. Human papillomavirus type 16 sequence variation in cervical cancers a worldwide perspective. J Virol 71:2463-2472.
45. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 69:7743-7753.
46. Yang Z. 2007. PAML4: Phylogenetic analysis by maximum likelihood. Mol Biol Evol 24:1586-1591.
47. Yue YF, Yang LJ, Chen JY, Pan Y, Zhao YJ., et al. 2012. Genetic subtypes and distribution of HPV from 3000 volunteer outpatients in Yunnan Province. Chinese Journal of Obstetrics & gynecology and pediatrics (electronic edition) 8:467-470.
48. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M. 1998a. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 352:1441-1442.
49. Zehbe I, Wilander E, Delius H, Tommasino M. 1998b. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58:829-833.
50. zur Hausen H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350.
51. zur Hausen H. 2006. Perspectives of contemporary papillomavirus research. Vaccine 24:3-4.